Le Lézard
Classified in: Health
Subjects: NPT, FVT

Neuropathy Action Foundation Announces 12th Annual "Neuropathy Action Awareness Day," Largest Neuropathy-Related Patient Event In The United States


LOS ANGELES, March 21, 2018 /PRNewswire-USNewswire/ -- The Neuropathy Action Foundation (NAF) announced that registration is now open for its 12th Annual "Neuropathy Action Awareness Day," an all-day educational event on June 22 in Los Angeles. "Neuropathy Action Awareness Day" is the largest neuropathy gathering in the United States and brings together patients and caregivers from across the country to learn about neuropathy, strategies for managing the condition, patient advocacy and tools that empower patients to become advocates for their own health care.

The event consists of educational presentations, luncheon, exhibit area and silent auction. Celebrity Internist, Melina Jampolis, MD, will speak during the luncheon.  Other speakers include:

"This event provides patients with a rare opportunity to empower themselves to become effective advocates for their own care," said NAF President Dominick Spatafora. "As insurance benefit restrictions make it more difficult to access IVIG and other medications, it is more important than ever that the neuropathy community has a strong voice to protect access to care and treatment."

The event is from 9:30 AM to 3:00 PM on Friday, June 22 at the Intercontinental Hotel located at 2151 Avenue of the Stars. The event is FREE of charge; however, NAF requests a $25 donation from patients and $125 from others. Register today at (877) 512-7262 or www.neuropathyaction.org  

Interested individuals who are unable to attend in person can register for free to stream the event online and submit questions digitally to be answered in real-time by event speakers.

About the Neuropathy Action Foundation
The Neuropathy Action Foundation (NAF), a 501(c)(3) non-profit, is dedicated to ensuring neuropathy patients obtain the necessary resources to access individualized treatment to improve their quality of life. The NAF increases awareness among physicians, the general public and public policy officials that neuropathy can potentially be a serious, widespread and disabling condition, which may be treatable when appropriate medical care is provided.

Media Contact: Dominick Spatafora, 877-512-7262, [email protected]

SOURCE Neuropathy Action Foundation


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: